Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)

NCT01371474 is registered in ClinicalTrials.gov with GlaxoSmithKline as lead sponsor.

NCT NCT01371474
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01371474 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Special Drug Use Investigation for PAXIL Tablet (Investigation in Case of Administered From 20mg/Day)
Lead sponsor
GlaxoSmithKline
Phase
Observational
Overall status
Completed
Start date
April 30, 2006
Completion date
June 30, 2008
Enrollment
1,483 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

panic disorder